[HTML][HTML] SARS-CoV-2 seroprevalence in COVID-19 hotspots

I Eckerle, B Meyer - The Lancet, 2020 - thelancet.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has surprised the world
with its range of disease manifestations, from asymptomatic infection to critical illness …

[HTML][HTML] COVID-19 serosurveys for public health decision making

MV Murhekar, H Clapham - The Lancet Global Health, 2021 - thelancet.com
During the first year of the COVID-19 pandemic, more than 90 million cases were reported
globally, with nearl y 2 million deaths. Case reporting depends on several factors, including …

[HTML][HTML] Seroprevalence of anti-SARS-CoV-2 antibodies after the second pandemic peak

S Stringhini, ME Zaballa, J Perez-Saez… - The Lancet. Infectious …, 2021 - ncbi.nlm.nih.gov
After the first pandemic wave in Europe, seroprevalence surveys revealed that roughly one
in ten individuals had been infected with severe acute respiratory syndrome coronavirus 2 …

[HTML][HTML] Testing for responses to the wrong SARS-CoV-2 antigen?

C Rosadas, P Randell, M Khan, MO McClure… - The Lancet, 2020 - thelancet.com
Two commercial antibody tests (Abbott SARS-CoV-2 IgG, Abbott Diagnostics, Abbott Park,
IL, USA; and Roche Elecsys Anti-SARS-CoV-2, Roche Diagnostics, Basel, Switzerland) …

[HTML][HTML] The COVID-19 pandemic in the USA: what might we expect?

G Chowell, K Mizumoto - Lancet (London, England), 2020 - ncbi.nlm.nih.gov
As of March 19, 2020, 191 127 cases of, including 7807 deaths attributed to, coronavirus
disease 2019 (COVID-19) have been reported worldwide. 1 The incidence of reported cases …

[HTML][HTML] Seroprevalence surveys in sub-Saharan Africa: what do they tell us?

E Usuf, A Roca - The Lancet Global Health, 2021 - thelancet.com
Initial estimates of the potential effect of SARS-CoV-2 virus in sub-Saharan Africa were
catastrophic: 1 fortunately, these predictions have not been met in terms of number of cases …

[HTML][HTML] SeroTracker: a global SARS-CoV-2 seroprevalence dashboard

RK Arora, A Joseph, J Van Wyk, S Rocco… - The Lancet Infectious …, 2021 - thelancet.com
As the initial phase of the COVID-19 pandemic passes its peak in many countries,
serological studies are becoming increasingly important in guiding public health responses …

No time for complacency on COVID-19 in Europe

A Flahault, A Calmy, D Costagliola, O Drapkina… - The Lancet, 2023 - thelancet.com
Long Covid. 6, 7 Persisting absenteeism from work linked to COVID-19 and to other
circulating respiratory viruses since the lifting of public health measures has had negative …

[HTML][HTML] Who is most likely to be infected with SARS-CoV-2?

RE Jordan, P Adab - The Lancet. Infectious Diseases, 2020 - ncbi.nlm.nih.gov
Comment 996 www. thelancet. com/infection Vol 20 September 2020 important new
contribution with high-quality statistical methods that allow quantification of independent …

COVID-19: towards controlling of a pandemic

J Bedford, D Enria, J Giesecke, DL Heymann… - The lancet, 2020 - thelancet.com
WHO Research and Development Blueprint Scientific Advisory Group that met on March 2,
2020, in Geneva, Switzerland, to prioritise the recommendations of an earlier meeting on …